John Leonard is President, Chief Executive Officer of Intellia Therapeutics, Inc. (NTLA). The company reported total compensation of $5,063,899 for fiscal year 2025.
| Salary | $708,000 |
|---|---|
| Bonus | $529,230 |
| Stock awards | $2,443,920 |
| Option awards | $1,356,320 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $26,429 |
| Total | $5,063,899 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Intellia Therapeutics, Inc. filed April 30, 2026, accession 0001193125-26-197283.
| Peer-group chief executive median | $5,977,309 |
|---|---|
| Difference from that median | $-913,410 |
| Percentile within the disclosed peer group | 39th |
| Peers with a disclosed figure | 18 |
Medians and percentiles are computed across the peer group Intellia Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| John Leonard this page | President, Chief Executive Officer | $5,063,899 |
| Edward Dulac | Executive Vice President, Chief Financial Officer and Treasurer | $2,168,505 |
| David Lebwohl | Executive Vice President, Chief Medical Officer | $1,984,724 |
| James Basta | Executive Vice President, General Counsel and Corporate Secretary | $1,846,597 |
| Birgit Schultes | Executive Vice President, Chief Scientific Officer | $1,740,083 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Intellia Therapeutics, Inc. compensation brief.
John Leonard's compensation sits inside Intellia Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.